Grundlæggende statistik
| Insider-profil | Frazier Life Sciences Public Fund, L.P. |
| Porteføljeværdi | $ 617.090.550 |
| Nuværende stillinger | 23 |
| Aktiviststillinger | 23 |
13D/G-arkivering
Dette er en liste over 13D- og 13G-arkiveringer lavet i det sidste år (hvis nogen). Klik på linkikonet for at se den fulde transaktionshistorik. Grønne rækker angiver nye positioner. Røde rækker angiver lukkede positioner.
| Fil dato | Form | Sikkerhed | Forrige Aktier |
Nuværende Aktier |
Δandele % | % Ejerskab |
% ΔEjerskab | |
|---|---|---|---|---|---|---|---|---|
| 2025-09-17 | HLVX / HilleVax, Inc. | 10.639.562 | 0 | -100,00 | 0,00 | -100,00 | ||
| 2025-08-20 | MBX / MBX Biosciences, Inc. | 5.985.347 | 4.557.097 | -23,86 | 13,60 | -27,66 | ||
| 2025-08-20 | KALV / KalVista Pharmaceuticals, Inc. | 4.887.867 | 2.400.276 | -50,89 | 4,80 | -52,00 | ||
| 2025-08-20 | PHAT / Phathom Pharmaceuticals, Inc. | 14.429.990 | 5.985.327 | -58,52 | 8,60 | -56,78 | ||
| 2025-08-14 | MAZE / Maze Therapeutics, Inc. | 4.451.339 | 3.352.915 | -24,68 | 7,70 | -24,51 | ||
| 2025-08-14 | PVLA / Palvella Therapeutics, Inc. | 690.012 | 545.504 | -20,94 | 4,90 | -22,22 | ||
| 2025-08-14 | LXEO / Lexeo Therapeutics, Inc. | 5.500.812 | 3.073.467 | -44,13 | 5,70 | -42,42 | ||
| 2025-08-14 | MREO / Mereo BioPharma Group plc - Depositary Receipt (Common Stock) | 40.349.315 | 32.430.690 | -19,63 | 4,10 | -19,61 | ||
| 2025-08-14 | SVRA / Savara Inc. | 11.462.301 | 6.745.296 | -41,15 | 3,90 | -40,91 | ||
| 2025-08-14 | IRON / Disc Medicine, Inc. | 1.754.834 | 1.026.489 | -41,51 | 3,00 | -49,15 | ||
| 2025-08-14 | ERAS / Erasca, Inc. | 22.575.851 | 15.038.753 | -33,39 | 5,30 | -33,75 | ||
| 2025-08-14 | ELEV / Elevation Oncology, Inc. | 5.993.579 | 0 | -100,00 | 0,00 | -100,00 | ||
| 2025-08-14 | ADVM / Adverum Biotechnologies, Inc. | 10.416.666 | 1.129.057 | -89,16 | 5,40 | 8,00 | ||
| 2025-08-14 | MGNX / MacroGenics, Inc. | 3.175.665 | 1.549.193 | -51,22 | 2,50 | -50,98 | ||
| 2025-08-14 | XLO / Xilio Therapeutics, Inc. | 5.747.193 | 8.141.017 | 41,65 | 9,90 | 0,00 | ||
| 2025-08-14 | JBIO / Jade Biosciences, Inc. | 1.772.116 | 1.340.703 | -24,34 | 4,20 | -23,64 | ||
| 2025-08-14 | AURA / Aura Biosciences, Inc. | 6.315.678 | 3.113.550 | -50,70 | 5,00 | -49,49 | ||
| 2025-05-15 | TRVI / Trevi Therapeutics, Inc. | 10.664.774 | 10.259.409 | -3,80 | 10,60 | -10,92 | ||
| 2025-05-15 | ORIC / ORIC Pharmaceuticals, Inc. | 4.142.855 | 1.410.193 | -65,96 | 2,00 | -67,74 | ||
| 2025-02-14 | ANAB / AnaptysBio, Inc. | 1.917.191 | 1.655.295 | -13,66 | 5,40 | -22,86 | ||
| 2025-02-14 | ELDN / Eledon Pharmaceuticals, Inc. | 3.561.644 | 1.176.735 | -66,96 | 2,00 | -67,21 | ||
| 2025-02-14 | PBYI / Puma Biotechnology, Inc. | 2.631.713 | 0 | -100,00 | 0,00 | -100,00 | ||
| 2025-02-14 | ANTX / AN2 Therapeutics, Inc. | 0 | 0,00 |
